Literature DB >> 8575072

In vivo survival and function of transplanted rat cardiomyocytes.

R K Li1, D A Mickle, R D Weisel, J Zhang, M K Mohabeer.   

Abstract

Recent studies have demonstrated the feasibility of transplanting fetal mouse cardiomyocytes into the hearts of adult syngeneic mice. However, the function of the transplanted cardiomyocytes and their capacity to survive in fibrous connective tissue were not assessed. In the present study, we evaluated the viability and contractility of transplanted fetal and neonatal rat cardiomyocytes in the connective tissue of the adult rat hindlimb. Purified fetal or neonatal rat cardiomyocytes were cultured. These cells contained sarcomeres, formed junctions composed of desmosomes and fascia adherens, and contracted regularly and spontaneously. A fetal or neonatal cardiomyocyte suspension was injected into the subcutaneous tissue of adult rat hindlimbs. Cyclosporin A (5 mg/kg) was administered subcutaneously daily for the 3-month duration of the study, at which time the animals were killed. The transplanted cardiomyocytes formed 'tissue' in vivo that increased in size for the first 2 weeks and remained the same size at the third week. The tissue derived from the transplanted fetal cardiomyocytes contracted spontaneously at a rate of 73 +/- 12 bpm, and that from the neonatal cardiomyocytes contracted at a rate of 43 +/- 21 bpm. The electrocardiogram was similar to that seen in myocardium with an idioventricular rhythm. Histologically, the tissue appeared to be cardiac muscle with sarcomeres. Angiogenesis occurred in the cardiomyocyte graft. In summary, a cell suspension of cultured fetal and neonatal rat cardiomyocytes transplanted into the adult rat hindlimb formed contractile cardiac tissue in the subcutaneous connective tissue.

Entities:  

Mesh:

Year:  1996        PMID: 8575072     DOI: 10.1161/01.res.78.2.283

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Bio-stretch, a computerized cell strain apparatus for three-dimensional organotypic cultures.

Authors:  M Liu; S Montazeri; T Jedlovsky; R Van Wert; J Zhang; R K Li; J Yan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-02       Impact factor: 2.416

Review 2.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 3.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

4.  Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells in vivo.

Authors:  Carolyn Holladay; Karen Power; Michael Sefton; Timothy O'Brien; William M Gallagher; Abhay Pandit
Journal:  Mol Ther       Date:  2011-01-25       Impact factor: 11.454

5.  Cardiogenic differentiation of mesenchymal stem cells on elastomeric poly (glycerol sebacate)/collagen core/shell fibers.

Authors:  Rajeswari Ravichandran; Jayarama Reddy Venugopal; Subramanian Sundarrajan; Shayanti Mukherjee; Seeram Ramakrishna
Journal:  World J Cardiol       Date:  2013-03-26

6.  Beating behavior of primary neonatal cardiomyocytes and cardiac-differentiated P19.CL6 cells on different extracellular matrix components.

Authors:  Azizi Miskon; Tomo Ehashi; Atsushi Mahara; Hiroshi Uyama; Tetsuji Yamaoka
Journal:  J Artif Organs       Date:  2009-06-18       Impact factor: 1.731

7.  Assessment of the effect of cardiomyocyte transplantation on left ventricular remodeling and function in post-infarction Wister rats by using high-frequency ultrasound.

Authors:  Jing Zhang; Mingxing Xie; Xinfang Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

Review 8.  Cardiac tissue engineering for replacement therapy.

Authors:  Wolfram-Hubertus Zimmermann; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

9.  GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.

Authors:  Mohammad Hossein Noyan-Ashraf; M Abdul Momen; Kiwon Ban; Al-Muktafi Sadi; Yu-Qing Zhou; Ali M Riazi; Laurie L Baggio; R Mark Henkelman; Mansoor Husain; Daniel J Drucker
Journal:  Diabetes       Date:  2009-01-16       Impact factor: 9.461

Review 10.  Engineering tissue from human embryonic stem cells.

Authors:  C M Metallo; S M Azarin; L Ji; J J de Pablo; S P Palecek
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.